For the ninth year, the Department of Ophthalmology has received an unrestricted grant from Research to Prevent Blindness to support research on vision processes and disease.
Paul Wietig, EdD, assistant vice president in the Office of Interprofessional Education, is one of 58 people nationwide to receive the FBI Director’s Community Leadership Award.
Family Medicine faculty are playing key roles in a $5.8 million clinical trial to improve care and outcomes for patients with coexisting diabetes, hypertension and chronic kidney disease.
A University at Buffalo pilot study using high-resolution magnetic resonance imaging (MRI) links dietary habits with iron levels in the brain — a factor associated with various neurological conditions as well as aging.
The UB School of Medicine and Biomedical Sciences continues to prepare for its move downtown by growing faculty ranks, improving its research productivity and increasing its presence on the Buffalo Niagara Medical Campus, said Michael E. Cain, MD.
An international team led by Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, has created a nanoparticle that may pave the way for “hypermodal” imaging — the ability to merge results from six different imaging modes using one contrast agent.
University at Buffalo researchers have designed a biomedical device that could make chemotherapy more efficient, reduce its side effects and improve how doctors treat some of the most deadly forms of cancer.
More aspiring doctors are applying to the University at Buffalo School of Medicine and Biomedical Sciences, and more accepted students are choosing UB, according to school officials.
With the goal of improving chemotherapy, Jennifer A. Surtees, PhD, associate professor of biochemistry, will study what makes cancer cells sensitive or resistant to different DNA-damaging drugs.
Using mechanical stress, scientists at the University at Buffalo and colleagues have turned normal cells into ‘stem-like’ cells, suggesting a possible safe, new way to produce stem cells.
University at Buffalo research on acetylcholine receptors (AChR) will help pharmacologists better understand how drugs work and could help make “receptor engineering” a reality.